全文获取类型
收费全文 | 3137篇 |
免费 | 226篇 |
国内免费 | 2篇 |
学科分类
医药卫生 | 3365篇 |
出版年
2023年 | 17篇 |
2022年 | 21篇 |
2021年 | 64篇 |
2020年 | 64篇 |
2019年 | 57篇 |
2018年 | 78篇 |
2017年 | 70篇 |
2016年 | 67篇 |
2015年 | 86篇 |
2014年 | 99篇 |
2013年 | 151篇 |
2012年 | 223篇 |
2011年 | 270篇 |
2010年 | 150篇 |
2009年 | 125篇 |
2008年 | 206篇 |
2007年 | 234篇 |
2006年 | 198篇 |
2005年 | 203篇 |
2004年 | 184篇 |
2003年 | 183篇 |
2002年 | 165篇 |
2001年 | 22篇 |
2000年 | 33篇 |
1999年 | 42篇 |
1998年 | 48篇 |
1997年 | 29篇 |
1996年 | 20篇 |
1995年 | 24篇 |
1994年 | 15篇 |
1993年 | 9篇 |
1992年 | 16篇 |
1991年 | 16篇 |
1990年 | 15篇 |
1989年 | 8篇 |
1988年 | 9篇 |
1987年 | 16篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 12篇 |
1983年 | 10篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1976年 | 5篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1969年 | 8篇 |
1963年 | 4篇 |
排序方式: 共有3365条查询结果,搜索用时 500 毫秒
71.
Martin Christ Katharina Isabel von Auenmueller Jeanette Liebeton Martin Grett Wolfgang Dierschke Jan Peter Noelke Irini Maria Breker Hans-Joachim Trappe 《International journal of medical sciences》2015,12(4):306-311
Objectives and Background: Despite a generally broad use of vascular closure devices (VCDs), it remains unclear whether they can also be used in victims from out-of-hospital cardiac arrest (OHCA) treated with mild therapeutic hypothermia (MTH).Methods: All victims from OHCA who received immediate coronary angiography after OHCA between January 1st 2008 and December 31st 2013 were included in this study. The operator decided to either use a VCD (Angio-Seal™) or manual compression for femoral artery puncture. The decision to induce MTH was based on the clinical circumstances.Results: 76 patients were included in this study, 46 (60.5%) men and 30 (39.5%) women with a mean age of 64.2 ± 12.8 years. VCDs were used in 26 patients (34.2%), and 48 patients (63.2%) were treated with MTH. While there were significantly more overall vascular complications in the group of patients treated with MTH (12.5% versus 0.0%; p=0.05), vascular complications were similar between patients with VCD or manual compression, regardless of whether or not they were treated with MTH.Conclusion: In our study, the overall rate of vascular complications related to coronary angiography was higher in patients treated with mild therapeutic hypothermia, but was not affected by the application of a vascular closure device. Therefore, our data suggest that the use of VCDs in victims from OHCA might be feasible and safe in patients treated with MTH as well, at least if the decision to use them is individually carefully determined. 相似文献
72.
Lodi C.W. Roksnoer Koen Verdonk Ingrid M. Garrelds Jeanette M.G. van Gool Robert Zietse Ewout J. Hoorn A.H. Jan Danser 《Clinical journal of the American Society of Nephrology》2014,9(7):1163-1167
Background and objectives
Alge et al. recently reported that urinary renin may be a prognostic biomarker for AKI after cardiac surgery. However, their urinary renin levels far exceeded published plasma renin levels, whereas normally, urinary renin is <10% of plasma renin. This result raises questions about the specificity of the new Quantikine Renin ELISA Kit used in the work by Alge et al., which is claimed to detect total renin (i.e., renin and prorenin). Therefore, this study tested this assay.Design, setting, participants, & measurements
Plasma and urine from 30 patients with hypertension, diabetes, or preeclampsia and 10 healthy pregnant women (randomly selected from sample sets obtained earlier to investigate urinary renin-angiotensin system components) were used to compare the ELISA with a validated renin immunoradiometric assay and an in-house enzyme kinetic assay. Measurements were performed before and after in vitro prorenin activation, representing renin and total renin, respectively.Results
Total renin measurements by ELISA, immunoradiometric assay, and enzyme kinetic assay were highly correlated. However, ELISA results were consistently ≥10-fold higher. The ELISA standard yielded low to undetectable levels in the immunoradiometric assay and enzyme kinetic assay, except after prorenin activation, when the results were ≥10-fold lower than the ELISA results. In plasma, prorenin activation increased ELISA results by 10%–15%. Urine contained no detectable prorenin.Conclusions
The ELISA renin kit standard is prorenin, and its immunoreactivity and enzymatic activity after conversion to renin do not match the International Reference Preparation of human renin that has been used to validate previous immunoradiometric assays and enzyme kinetic assays; in fact, they are at least 10-fold lower, and thus, any measurements obtained with this ELISA kit yield levels that are at least 10-fold too high. The ELISA antibodies detect both renin and prorenin, with a preference for the former. Given these inconsistencies, urinary renin levels should be measured by established renin assays. 相似文献73.
74.
Lee LF Logronio K Tu GH Zhai W Ni I Mei L Dilley J Yu J Rajpal A Brown C Appah C Chin SM Han B Affolter T Lin JC 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(31):12674-12679
Genetic variation in the IL-7 receptor-α (IL-7R) gene is associated with susceptibility to human type 1 diabetes (T1D). Here we investigate the therapeutic efficacy and mechanism of IL-7Rα antibody in a mouse model of T1D. IL-7Rα antibody induces durable, complete remission in newly onset diabetic mice after only two to three injections. IL-7 increases, whereas IL-7Rα antibody therapy reduces, the IFN-γ-producing CD4(+) (T(H)1) and IFN-γ-producing CD8(+) T cells. Conversely, IL-7 decreases and IL-7Rα antibody enhances the inhibitory receptor Programmed Death 1 (PD-1) expression in the effector T cells. Programmed Death 1 blockade reversed the immune tolerance mediated by the IL-7Rα antibody therapy. Furthermore, IL-7Rα antibody therapy increases the frequency of regulatory T cells without affecting their suppressor activity. The durable efficacy and the multipronged tolerogenic mechanisms of IL-7Rα antibody therapy suggest a unique disease-modifying approach to T1D. 相似文献
75.
ILR Genetics Consortium Emerging Risk Factors Collaboration Sarwar N Butterworth AS Freitag DF Gregson J Willeit P Gorman DN Gao P Saleheen D Rendon A Nelson CP Braund PS Hall AS Chasman DI Tybjærg-Hansen A Chambers JC Benjamin EJ Franks PW Clarke R Wilde AA Trip MD Steri M Witteman JC Qi L van der Schoot CE de Faire U Erdmann J Stringham HM Koenig W Rader DJ Melzer D Reich D Psaty BM Kleber ME Panagiotakos DB Willeit J Wennberg P Woodward M Adamovic S Rimm EB Meade TW Gillum RF Shaffer JA 《Lancet》2012,379(9822):1205-1213
76.
Charchar FJ Bloomer LD Barnes TA Cowley MJ Nelson CP Wang Y Denniff M Debiec R Christofidou P Nankervis S Dominiczak AF Bani-Mustafa A Balmforth AJ Hall AS Erdmann J Cambien F Deloukas P Hengstenberg C Packard C Schunkert H Ouwehand WH Ford I Goodall AH Jobling MA Samani NJ Tomaszewski M 《Lancet》2012,379(9819):915-922
77.
Haufe S Utz W Engeli S Kast P Böhnke J Pofahl M Traber J Haas V Hermsdorf M Mähler A Busjahn A Wiesner S Otto C Mehling H Luft FC Boschmann M Schulz-Menger J Jordan J 《Hypertension》2012,59(1):70-75
In animals, carbohydrate and fat composition during dietary interventions influenced cardiac metabolism, structure, and function. Because reduced-carbohydrate and reduced-fat hypocaloric diets are commonly used in the treatment of obesity, we investigated whether these interventions differentially affect left ventricular mass, cardiac function, and blood pressure. We randomized 170 overweight and obese subjects (body mass index, 32.9±4.4; range, 26.5-45.4 kg/m(2)) to 6-month hypocaloric diets with either reduced carbohydrate intake or reduced fat intake. We obtained cardiac MRI and ambulatory blood pressure recordings over 24 hours before and after 6 months. Ninety subjects completing the intervention period had a full cardiac MRI data set. Subjects lost 7.3±4.0 kg (7.9±3.8%) with reduced-carbohydrate diet and 6.2±4.2 kg (6.7±4.4%) with reduced-fat diet (P<0.001 within each group; P=not significant between interventions). Caloric restriction led to similar significant decreases in left ventricular mass with low-carbohydrate diets (5.4±5.4 g) or low-fat diets (5.2±4.8 g; P<0.001 within each group; P=not significant between interventions). Systolic and diastolic left ventricular function did not change with either diet. The 24-hour systolic blood pressure decreased similarly with both interventions. Body weight change (β=0.33; P=0.02) and percentage of ingested n-3 polyunsaturated fatty acids (β=-0.27; P=0.03) predicted changes in left ventricular mass. In conclusion, weight loss induced by reduced-fat diets or reduced-carbohydrate diets similarly improved left ventricular mass in overweight and obese subjects over a 6-month period. However, n-3 polyunsaturated fatty acid ingestion may have an independent beneficial effect on left ventricular mass. 相似文献
78.
Stow LR Richards J Cheng KY Lynch IJ Jeffers LA Greenlee MM Cain BD Wingo CS Gumz ML 《Hypertension》2012,59(6):1151-1156
The circadian clock protein period 1 (Per1) contributes to the regulation of expression of the α subunit of the renal epithelial sodium channel at the basal level and in response to the mineralocorticoid hormone aldosterone. The goals of the present study were to define the role of Per1 in the regulation of additional renal sodium handling genes in cortical collecting duct cells and to evaluate blood pressure (BP) in mice lacking functional Per1. To determine whether Per1 regulates additional genes important in renal sodium handling, a candidate gene approach was used. Immortalized collecting duct cells were transfected with a nontarget small interfering RNA or a Per1-specific small interfering RNA. Expression of the genes for α-epithelial sodium channel and Fxyd5, a positive regulator of Na, K-ATPase activity, decreased in response to Per1 knockdown. Conversely, mRNA expression of caveolin 1, Ube2e3, and ET-1, all negative effectors of epithelial sodium channel, was induced after Per1 knockdown. These results led us to evaluate BP in Per1 KO mice. Mice lacking Per1 exhibit significantly reduced BP and elevated renal ET-1 levels compared with wild-type animals. Given the established role of renal ET-1 in epithelial sodium channel inhibition and BP control, elevated renal ET-1 is one possible explanation for the lower BP observed in Per1 KO mice. These data support a role for the circadian clock protein Per1 in the coordinate regulation of genes involved in renal sodium reabsorption. Importantly, the lower BP observed in Per1 KO mice compared with wild-type mice suggests a role for Per1 in BP control as well. 相似文献
79.
80.